Bayer raises full-year targets, CEO sees turning point
Bayer raised its full-year targets, with its CEO describing the company as at a “turning point.”
Story updates
07:10:39 AM UTC
SquawkNews
By Adria CalatayudBayer raised its full-year earnings guidance, citing a recovery in its pharmaceutical arm after strong demand for key drugs allowed the group to offset market pressures at its agricultural and consumer-health divisions.The German group said Tuesday that it now expects full-year ea…